Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zepp Health (ZEPP) EBITDA: 2016-2025

Historic EBITDA for Zepp Health (ZEPP) over the last 9 years, with Sep 2025 value amounting to -$884,000.

  • Zepp Health's EBITDA rose 92.95% to -$884,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.3 million, marking a year-over-year increase of 8.99%. This contributed to the annual value of -$47.2 million for FY2024, which is 55.17% down from last year.
  • Zepp Health's EBITDA amounted to -$884,000 in Q3 2025, which was up 85.51% from -$6.1 million recorded in Q2 2025.
  • Zepp Health's EBITDA's 5-year high stood at $277.4 million during Q4 2022, with a 5-year trough of -$155.4 million in Q1 2022.
  • Its 3-year average for EBITDA is -$9.4 million, with a median of -$8.9 million in 2024.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 2,656.15% in 2022, then crashed by 1,527.80% in 2024.
  • Over the past 5 years, Zepp Health's EBITDA (Quarterly) stood at $10.1 million in 2021, then soared by 2,656.15% to $277.4 million in 2022, then slumped by 99.77% to $626,000 in 2023, then tumbled by 1,527.80% to -$8.9 million in 2024, then skyrocketed by 92.95% to -$884,000 in 2025.
  • Its last three reported values are -$884,000 in Q3 2025, -$6.1 million for Q2 2025, and -$18.4 million during Q1 2025.